MELANOTAN I

Skin, Hair & CosmeticResearch Only

Moderate evidence from a small collection of studies, but most research consists of observational data rather than rigorous controlled trials. The single randomized trial and various case studies suggest real tanning effects, though the evidence quality lags behind established treatments.

Primarily studied by dermatology researchers investigating photosensitivity disorders and alternative approaches to skin pigmentation, with some cosmetic research applications.

FDA Status

Research Only

Since Feb 2026

Evidence

Moderate

Studies

13 total, 1 human

What is MELANOTAN I?

Originally developed as a potential treatment for skin conditions like erythropoietic protoporphyria, this synthetic analog of alpha-melanocyte stimulating hormone has gained attention primarily for its ability to stimulate melanin production and create a tan without UV exposure. Unlike its more widely known cousin Melanotan II, this peptide shows much more selective activity at melanocortin receptors, potentially reducing unwanted side effects.

The peptide works by binding specifically to melanocortin-1 receptors found on melanocytes in the skin, triggering a cascade that increases production of eumelanin, the dark pigment responsible for tanning. This selective receptor targeting means it primarily affects pigmentation pathways while largely avoiding the appetite suppression and sexual effects seen with broader-acting melanocortin agonists.

What the Research Shows

Limited to 13 studies with only one randomized controlled trial, and much of the available data comes from surveys of recreational users rather than controlled clinical research.

Based on 13 human studies (1 RCT), melanotan I demonstrated significant tanning effects with complete subcutaneous bioavailability and effects persisting 3 weeks post-treatment, though the evidence base consists primarily of observational research including surveys of illicit users rather than rigorous controlled trials comparing efficacy to established hyperpigmentation treatments like triple therapy with hydroquinone, tretinoin, and steroids.